Stanniocalcin 1 induction by thyroid hormone depends on thyroid hormone receptor and phosphatidylinositol 3-kinase activation

Experimental and Clinical Endocrinology and Diabetes

Volumn 119, Issue 2, 2011, Pages 81-85

  Moeller, L C ^a   Haselhorst, N E ^a   Dumitrescu, A M ^b   Cao, X ^c   Seo, H ^c   Refetoff, S ^b   Mann, K ^a   Janssen, O E ^a,d  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF CHICAGO   (United States)

^c NAGOYA UNIVERSITY   (Japan)

^d ENDOKRINOLOGIKUM HAMBURG   (Germany)

Author keywords

HIF 1; hypoxia inducible factor 1; nongenomic action

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYCLOHEXIMIDE; HYPOCALCIN; LIOTHYRONINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P85; STANNIOCALCIN 1; THYROID HORMONE; THYROID HORMONE RECEPTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CYTOSOL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN FIBROBLAST;

CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FIBROBLASTS; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMANS; MUTANT PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN BIOSYNTHESIS; THYROID HORMONE RECEPTORS BETA; THYROID HORMONE RESISTANCE SYNDROME; TRANSCRIPTIONAL ACTIVATION; TRIIODOTHYRONINE;

EID: 79651475562     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0030-1262860     Document Type: Article

References (25)

1. Cao X, Kambe F, Moeller LC, et al. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol (Pubitemid 40065962)
2. Chakraborty A, Brooks HL, Zhang P, et al. Stanniocalcin-1 regulates endothelial gene expression and modulates trans-endothelial migration of leukocytes. Am J Physiol Renal Physiol 2007 292 895-904
3. Chang AC, Janosi J, Hulsbeek M, et al. A novel human cDNA highly homologous to the fish hormone stanniocalcin. Mol Cell Endocrinol 1995 112 241-247
4. Chang AC, Jellinek DA, Reddel RR. Mammalian stanniocalcins and cancer. Endocr Relat Cancer 2003 10 359-373 (Pubitemid 37267555)
5. Cheng SY, Leonard JL, Davis PJ. Molecular Aspects of Thyroid Hormone Actions. Endocr Rev 2010 31 139-170
6. Davis FB, Mousa SA, O'Connor L, et al. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circ Res 2004 94 1500-1506 (Pubitemid 38780323)
7. Davis FB, Tang HY, Shih A, et al. Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells. Cancer Res 2006 66 7270-7275 (Pubitemid 44197708)
8. Filvaroff EH, Guillet S, Zlot C, et al. Stanniocalcin 1 alters muscle and bone structure and function in transgenic mice. Endocrinology 2002 143 3681-3690 (Pubitemid 34925745)
9. Furuya F, Hanover JA, Cheng SY. Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor. Proc Natl Acad Sci USA 2006 103 1780-1785 (Pubitemid 43228770)
10. Lal A, Peters H, St Croix B, et al. Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 2001 93 1337-1343 (Pubitemid 32910575)
11. Law AY, Ching LY, Lai KP, et al. Identification and characterization of the hypoxia-responsive element in human stanniocalcin-1 gene. Mol Cell Endocrinol 2010 314 118-127
12. Lei J, Mariash CN, Ingbar DH. 3,3,5-Triiodo-L-thyronine up-regulation of Na, K-ATPase activity and cell surface expression in alveolar epithelial cells is Src kinase- and phosphoinositide 3-kinase-dependent. J Biol Chem 2004 279 47589-47600 (Pubitemid 39540904)
13. Livak KJS, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001 25 402-408 (Pubitemid 34164012)
14. Madsen KL, Tavernini MM, Yachimec C, et al. Stanniocalcin: a novel protein regulating calcium and phosphate transport across mammalian intestine. Am J Physiol 1998 274 G96-G102
15. McCudden CR, James KA, Hasilo C, et al. Characterization of mammalian stanniocalcin receptors. Mitochondrial targeting of ligand and receptor for regulation of cellular metabolism. J Biol Chem 2002 277 45249-45258 (Pubitemid 36159130)
16. Moeller LC, Cao X, Dumitrescu AM, et al. Thyroid hormone mediated changes in gene expression can be initiated by cytosolic action of the thyroid hormone receptor beta through the phosphatidylinositol 3-kinase pathway. Nucl Recept Signal 2006 4 e020
17. Moeller LC, Dumitrescu AM, Refetoff S. Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and glycolytic genes. Mol Endocrinol 2005a 19 2955-2963 (Pubitemid 41697714)
18. Moeller LC, Dumitrescu AM, Walker RL, et al. Thyroid hormone responsive genes in cultured human fibroblasts. J Clin Endocrinol Metab. 2005b 90 936-943 (Pubitemid 40279219)
19. Murata Y, Ceccarelli P, Refetoff S, et al. Thyroid hormone inhibits fibronectin synthesis by cultured human skin fibroblasts. J Clin Endocrinol Metab 1987 64 334-339 (Pubitemid 17001067)
20. Samuels HH, Stanley F, Casanova J. Depletion of L-3,5,3-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology 1979 105 80-85 (Pubitemid 9199127)
21. Sheikh-Hamad D, Bick R, Wu GY, et al. Stanniocalcin-1 is a naturally occurring L-channel inhibitor in cardiomyocytes: relevance to human heart failure. Am J Physiol Heart Circ Physiol 2003 285 H442-H448 (Pubitemid 36736460)
22. Ullah MS, Davies AJ, Halestrap AP. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem 2006 281 9030-9037 (Pubitemid 43864615)
23. Wagner GFD, Dimattia GE. The stanniocalcin family of proteins. J Exp Zoolog A Comp Exp Biol 2006 305 769-780 (Pubitemid 44358304)
24. Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev 2001 81 1097-1142 (Pubitemid 32606667)
25. Yeung HY, Lai KP, Chan HY, et al. Hypoxia-inducible factor-1-mediated activation of stanniocalcin-1 in human cancer cells. Endocrinology 2005 146 4951-4960 (Pubitemid 41446634)